MRNA short sellers face ~$4.8B paper losses after jump to $159
Moderna (MRNA) short sellers face about $4.8B in paper losses on Wednesday after the stock surges to $159, according to Ortex estimates.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.